Skip to main content
Levitee Labs Inc. logo

Levitee Labs Inc. — Investor Relations & Filings

Ticker · LVT ISIN · CA5274241051 LEI · 254900LJ1KD4EB3C0N68 CSE Human health and social work activities
Open in API
Filings indexed 50 across all filing types
Latest filing 2022-09-17 Capital/Financing Update
Country CA Canada
Listing CSE LVT

About Levitee Labs Inc.

http://leviteelabs.com/

Levitee Labs Inc. is an integrative wellness company focused on redefining mental healthcare and addiction treatment through preventative, restorative, and transformative methods. The company operates a diversified portfolio of healthcare and wellness assets, specializing in the delivery of evidence-based novel psychedelic therapies. Levitee Labs also develops and sells functional mushroom products, including high-potency extract nutraceuticals, through operating units such as Monk-E Nutraceuticals and Sporeo Supply. Its core strategy involves the centralization and accretive acquisition of cash-flowing integrative wellness assets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the sale of assets (Earth Circle) and the terms of a credit facility amendment with RiverFort Global Capital. It details the transaction terms, financing agreement amendments, share issuances, and warrants. There are no financial statements, quarterly or annual results, or detailed financial analysis. The content focuses on financing and capital structure updates, including loan agreements and share issuance terms. It is not an earnings release, annual report, or audit report. The document is not a regulatory filing or report publication announcement but a substantive update on financing and capital activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-09-17 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 MATERIAL CHANGE REPORT, which is a regulatory filing used to disclose material changes in a company's affairs. The content describes the issuance of shares to settle debt, which is a material change event. The document is short (1680 characters) and structured as a formal regulatory disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of annual or interim reports. It is not an announcement of a report publication but a standalone regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-27 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the issuance of shares to settle a debt. It details the number of shares issued, the price, the debt amount, and conditions related to the issuance. There is no financial statement, quarterly or annual report, or detailed financial analysis. The content focuses on a capital transaction involving share issuance for debt settlement, which is a financing activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 6198 characters, which is sufficient for a detailed announcement but does not contain financial statements or management discussion. Hence, it is not an Annual Report, Interim Report, or Earnings Release. It is not a Regulatory Filing or Report Publication Announcement since it contains substantive information about the transaction itself, not just a notice or certification.
2022-04-26 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a non-brokered private placement financing by Levitee Labs. It details the offering price, number of units, use of proceeds, and terms of the warrants. There is no financial statement or detailed financial analysis included, only information about the capital raising activity. The document is not an annual or interim report, nor an earnings release or management discussion. It is clearly an update on the company's financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing, not just a brief announcement or link to a report, so it is not RPA or RNS.
2022-01-18 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the formation of a Medical Advisory Board for Levitee Labs, detailing the expertise of the board members, and describing the company's strategic direction and recent acquisitions. It includes no financial statements, no detailed financial performance data, no regulatory certifications, or voting results. It is not a report but an announcement of corporate developments and management appointments (CFO change). The content focuses on management and board-related information rather than financial results or regulatory filings. Therefore, the document best fits the category of Board/Management Information (MANG). The document length is substantial and contains detailed information about management-level appointments and advisory board formation, supporting a high confidence in this classification.
2022-01-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership between Levitee Labs and LiveRx Research Group to provide equitable access to Hepatitis C care in Alberta, Canada. It contains no financial statements, no regulatory filings, no voting results, no management or board changes, no earnings data, no audit information, and no detailed investor presentation. It is a corporate announcement about a business collaboration and healthcare initiative. The document length is about 11,799 characters, which is substantial but the content is clearly a news release about a partnership, not a financial or regulatory report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2021-12-20 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.